Benjamin F. Edwards & Company, Inc. Pacific Biosciences Of California, Inc. Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 141,830 shares of PACB stock, worth $259,548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141,830
Previous 2,422
5755.9%
Holding current value
$259,548
Previous $9,000
2055.56%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PACB
# of Institutions
255Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$61.1 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$43.2 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$42.8 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$37.2 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$32.3 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $411M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...